[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 78, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 57, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 892238, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 56, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 503280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 391236, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.94, "open": 0.94, "dayLow": 0.925, "dayHigh": 0.96, "regularMarketPreviousClose": 0.94, "regularMarketOpen": 0.94, "regularMarketDayLow": 0.925, "regularMarketDayHigh": 0.96, "beta": 0.242, "forwardPE": -0.723651, "volume": 60542, "regularMarketVolume": 60542, "averageVolume": 322940, "averageVolume10days": 70630, "averageDailyVolume10Day": 70630, "marketCap": 61341708, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 1.85, "fiftyDayAverage": 0.88212, "twoHundredDayAverage": 1.13795, "currency": "USD", "enterpriseValue": -16824280, "floatShares": 27776052, "sharesOutstanding": 65880900, "sharesShort": 35166, "sharesShortPriorMonth": 45418, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.0028799998, "heldPercentInstitutions": 0.66243, "shortRatio": 0.23, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 66510600, "bookValue": 1.101, "priceToBook": 0.8456858, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -90340000, "trailingEps": -1.29, "forwardEps": -1.17, "enterpriseToEbitda": 0.175, "52WeekChange": -0.3974359, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IOBT", "underlyingSymbol": "IOBT", "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "firstTradeDateEpochUtc": 1636119000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ea2848e4-aa90-3bf4-82a5-9ce691c6a8c0", "messageBoardId": "finmb_1685354464", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.9311, "targetHighPrice": 12.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 80185000, "totalCashPerShare": 1.217, "ebitda": -96169000, "totalDebt": 2019000, "quickRatio": 5.054, "currentRatio": 5.372, "debtToEquity": 2.782, "returnOnAssets": -0.45913, "returnOnEquity": -0.78503, "freeCashflow": -53427624, "operatingCashflow": -85517000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]